Exchange: NASDAQ·Updated 04:00 AM EDT
ACHV logo

ACHV Achieve Life Sciences Inc.

$7.54
$0.00
(0.00%)
Pre-Market
Prev Close $7.54
EarningsNov 5
Mkt Cap$775.88M
Vol2.00

About ACHV

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
44

Bearish Sentiment

How do you feel about ACHV?

Advertisement|Remove ads.